Resmed Inc. buy Royal Bank of Canada
Start price
15.07.25
/
50%
€220.80
Target price
15.07.26
€251.96
Performance (%)
-21.92%
End price
16.07.26
€172.40
Summary
This prediction ended on 16.07.26 with a price of €172.40. The price of Resmed Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.92%. Royal_Bank_of_Canada has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 5.421% | 5.421% | -23.214% |
| iShares Core DAX® | 3,26 % | 2,07 % | 10,10 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % | 28,97 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % | 52,09 % |
| iShares S&P 500 | 2,80 % | 2,25 % | 23,75 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $294.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten